Year |
Citation |
Score |
2017 |
Boyd NH, Walker K, Fried J, Hackney JR, McDonald PC, Benavides GA, Spina R, Audia A, Scott SE, Libby CJ, Tran AN, Bevensee MO, Griguer C, Nozell S, Gillespie GY, et al. Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. Jci Insight. 2. PMID 29263302 DOI: 10.1172/Jci.Insight.92928 |
0.415 |
|
2017 |
Lai YJ, Tsai JC, Tseng YT, Wu MS, Liu WS, Lam HI, Yu JH, Nozell SE, Benveniste EN. Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo. Oncotarget. PMID 28160553 DOI: 10.18632/oncotarget.14949 |
0.345 |
|
2015 |
Rajbhandari R, McFarland BC, Patel A, Gerigk M, Kenneth Gray G, Fehling SC, Bredel M, Berbari NF, Kim H, Marks MP, Meares GP, Sinha T, Chuang J, Benveniste EN, Nozell SE. Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma Oncotarget. 6: 17805-17816. |
0.323 |
|
2013 |
McFarland BC, Hong SW, Rajbhandari R, Twitty GB, Gray GK, Yu H, Benveniste EN, Nozell SE. NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma. Plos One. 8: e78728. PMID 24244348 DOI: 10.1371/journal.pone.0078728 |
0.325 |
|
2011 |
McFarland BC, Ma JY, Langford CP, Gillespie GY, Yu H, Zheng Y, Nozell SE, Huszar D, Benveniste EN. Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Molecular Cancer Therapeutics. 10: 2384-93. PMID 22027691 DOI: 10.1158/1535-7163.MCT-11-0480 |
0.435 |
|
2011 |
Zhao X, Laver T, Hong SW, Twitty GB, Devos A, Devos M, Benveniste EN, Nozell SE. An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas. Journal of Neuro-Oncology. 102: 367-81. PMID 21279667 DOI: 10.1007/S11060-010-0346-Y |
0.392 |
|
2009 |
Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene. 28: 3735-45. PMID 19668231 DOI: 10.1038/onc.2009.232 |
0.345 |
|
2008 |
Nozell S, Laver T, Moseley D, Nowoslawski L, De Vos M, Atkinson GP, Harrison K, Nabors LB, Benveniste EN. The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Molecular and Cellular Biology. 28: 6632-45. PMID 18779315 DOI: 10.1128/Mcb.00697-08 |
0.314 |
|
2004 |
Liu G, Nozell S, Xiao H, Chen X. DeltaNp73beta is active in transactivation and growth suppression. Molecular and Cellular Biology. 24: 487-501. PMID 14701724 DOI: 10.1128/Mcb.24.2.487-501.2004 |
0.39 |
|
2003 |
Nozell S, Wu Y, McNaughton K, Liu G, Willis A, Paik JC, Chen X. Characterization of p73 functional domains necessary for transactivation and growth suppression. Oncogene. 22: 4333-47. PMID 12853970 DOI: 10.1038/Sj.Onc.1206470 |
0.428 |
|
2003 |
Chen X, Liu G, Zhu J, Jiang J, Nozell S, Willis A. Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family. Cancer Biology & Therapy. 2: 55-62. PMID 12673118 DOI: 10.4161/Cbt.180 |
0.551 |
|
2002 |
Nozell S, Chen X. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene. 21: 1285-94. PMID 11850848 DOI: 10.1038/Sj.Onc.1205191 |
0.335 |
|
Show low-probability matches. |